Gossamer Bio, Inc.
GOSS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $13 | $11 | $10 | $9 |
| % Growth | 15.7% | 16.2% | 5.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $13 | $11 | $10 | $9 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $53 | $42 | $38 | $36 |
| G&A Expenses | $9 | $9 | $9 | $9 |
| SG&A Expenses | $9 | $9 | $9 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $62 | $50 | $47 | $46 |
| Operating Income | -$49 | -$39 | -$37 | -$36 |
| % Margin | -369.4% | -337.4% | -372.2% | -385.2% |
| Other Income/Exp. Net | $1 | $0 | $0 | $1 |
| Pre-Tax Income | -$48 | -$38 | -$37 | -$35 |
| Tax Expense | $0 | $0 | $0 | -$2 |
| Net Income | -$48 | -$38 | -$37 | -$33 |
| % Margin | -362.7% | -333.1% | -370.5% | -352.2% |
| EPS | -0.21 | -0.17 | -0.16 | -0.15 |
| % Growth | -23.5% | -6.3% | -6.7% | – |
| EPS Diluted | -0.21 | -0.17 | -0.16 | -0.15 |
| Weighted Avg Shares Out | 228 | 227 | 227 | 227 |
| Weighted Avg Shares Out Dil | 228 | 227 | 227 | 227 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $3 | $3 | $3 | $3 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$45 | -$35 | -$34 | -$32 |
| % Margin | -342% | -307.4% | -339.3% | -337.2% |